William Reardon - Tekla Healthcare Insider

XHQHX -- USA Fund  

USD 25.01  0.04  0.16%

Mr. William S. Reardon, CPA, is an Independent Trustee of HQ Healthcare Investors. Until 2002, Mr. Reardon was a business assurance partner in PwC Boston office and leader of the Life Sciences Industry Practice for New England and the Eastern U.S., working closely with many of the Firm public clients in SECregistered equity, convertible and RD limited partnership offerings and many initial public offerings. He serves on the Valuation and Audit Committees of each Fund. From 19982000 he served on the Board of the Emerging Companies Section of the Biotechnology Industry Organization and from 2000 to 2002 he served on the Board of Directors of the Massachusetts Biotechnology Council . During his professional career, he was a frequent speaker at BIO conferences and MBC Industry meetings on issues affecting biotechnology companies. He currently also serves as a board member and audit committee chair of two developmentstage public companies, Synta Pharmaceuticals and Idera Pharmaceuticals
Age: 70  Executive Since 2010  CPA    
Reardon is member of the American Institute of CPAs and the Massachusetts Society of CPAs, with an MBA from Harvard Business School and a BA in East Asian History from Harvard College.

William Reardon Latest Insider Activity

Management Performance (%)

Similar Money Managers

Found 11 records

One Year Return

Barbara MillerJPMorgan Core Bond R4
Barbara MillerJPMorgan Core Bond I
Bob MillerBlackRock Strategic Income Opps
Carl EichstaedtWestern Asset Core Plus Bond FI
James LovelaceAmerican Funds Capital Income B
Carl EichstaedtWestern Asset Core Plus Bond I
Rick RiederBlackRock Strategic Income Opps
Mark DenningAmerican Funds SMALLCAP World R
Daniel ShackelfordT Rowe Price New Income R
Dina PerryAmerican Funds Fundamental Invs
Andrew OBrienLord Abbett Short Duration Inco

Fund Summary

The fund is listed under null category and is part of null family.

Tekla Healthcare Inv Leadership Team

William Reardon, Independent Trustee
Michael Bonney, Independent Trustee
Oleg Pohotsky, Independent Chairman of the Board of Trustees
Laura Woodward, Chief Compliance Officer, Treasurer, Secretary
Lucinda Stebbins, Independent Trustee
Daniel Omstead, President Trustee
Uwe Reinhardt, Independent Trustee
Rakesh Jain, Independent Trustee

Fund Performance Indicators

Did you try this?

Run Price Transformation Now

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
All  Next Launch Price Transformation

Also Currentnly Active

Purchased over 20 shares of
a day ago
Traded for 106.27
Purchased over 200 shares of
a day ago
Traded for 10.56
Purchased over 70 shares of
a day ago
Traded for 39.4
See also Your Current Watchlist. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.